Pharmaceuticals News and Research

RSS

New weight loss treatment is marked by heavy marketing and modest results

First came the "edible billboard," which appeared last year during the holidays in New York's East Village loaded with cake treats. Then, in late January, came the national marketing campaign, with TV and digital media promoting the idea that trying to lose weight doesn't mean a person can't enjoy eating.

22 Jun 2022

Simplicity is key when it comes to ablation, global AFib study finds

Results from one of the largest global studies of atrial fibrillation (AFib) procedures show that the simple approach is usually best when it comes to ablation, a procedure where physicians destroy or ablate cardiac tissue to correct irregular heart rhythms.

21 Jun 2022

Insufficient drug exposure most likely to cause COVID-19 rebound

Paxlovid is the leading oral medication for preventing severe cases of COVID-19 in high-risk individuals.

21 Jun 2022

A proposal to import drugs from other countries creates an unusual alliance in the Senate

Harmony is not often found between two of the most boisterous senators on Capitol Hill, Bernie Sanders (I-Vt.) and Rand Paul (R-Ky.).

17 Jun 2022

Oral immunotherapy for peanut allergies is highly effective when started for infants under 12 months

UBC researchers demonstrated in 2019 that pre-schoolers can safely overcome peanut allergies with a treatment called oral immunotherapy.

16 Jun 2022

At a Bay Area ‘test-to-treat’ site, few takers for free antivirals

After avoiding movie theaters, restaurants, and gyms for more than two years, Helen Ho decided to take her first big risk since the start of the pandemic to attend her graduation.

16 Jun 2022

Study tracks neurological symptoms in COVID-19 "long-haulers"

Researchers at University of California San Diego School of Medicine are conducting a longitudinal study to track neurological symptoms in COVID-19 "long-haulers."

16 Jun 2022

Drug combinations may help to slow the progression of diabetic kidney disease

A mouse study led by Washington University School of Medicine in St. Louis suggests that combining SGLT2 inhibitors — a newer class of diabetes medications that lowers blood sugar — with older diabetes drugs may help to slow the progression of diabetic kidney disease.

15 Jun 2022

As Biden fights overdoses, harm reduction groups face local opposition

Casey Malish had just pulled into an intersection in the 2nd Ward when a woman with tattoos and pinkish hair unexpectedly hopped into the back seat of his gray Mazda. He handles outreach for the Houston Harm Reduction Alliance, a nonprofit that helps drug users like her stay alive.

14 Jun 2022

First-in-class, anti-cancer mitochondrial drug found to be effective against most carcinoma cell lines

A study of the lead agent (CPI-613) in a class of anticancer drugs undergoing Food and Drug Administration (FDA) approved clinical trials reveals that CPI-613 is effective against most carcinoma cell lines, and, used in combination, could have efficacy against reducing some tumors.

9 Jun 2022

KHN’s ‘What the Health?’: Taking a shot at gun control

The House passed a package of bills to restrict the availability of assault weapons to minors and other measures to curb gun violence, but talks in the Senate have yet to produce breakthroughs on what has been a legislative stalemate for years.

9 Jun 2022

Robotic finger covered with living skin tissue can heal itself

Researchers from the University of Tokyo pool knowledge of robotics and tissue culturing to create a controllable robotic finger covered with living skin tissue.

9 Jun 2022

Largest-ever series of case studies shows phage therapy’s success in more than half of the patients

The number of reported cases using viruses to treat deadly Mycobacterium infections just went up by a factor of five. In a new study, a team led by researchers from the University of Pittsburgh and the University of California San Diego report 20 new case studies on the use of the experimental treatment, showing the therapy's success in more than half of the patients.

9 Jun 2022

Lawmaker takes on insurance companies and gets personal about his health

Scott Wiener made a startling revelation at a spring legislative committee hearing: "I was in the hospital. I experienced the most intense abdominal pain that I could even imagine."

9 Jun 2022

Misinformation clouds America’s most popular emergency contraception

A brand of specialty mozzarella cheeses. A collection of natural-gas storage terminals. And America’s top-selling emergency contraception.

7 Jun 2022

Etiologies of liver cancer are changing and the prognosis is mixed, study says

The primary causes of liver cancer are well known: viral (hepatitis B and C), alcohol and non-alcoholic steatohepatitis (NASH), a condition in which fat builds up in the liver, resulting in chronic inflammation and damage.

7 Jun 2022

Taking everolimus post-surgery can improve outcomes in patients with high-risk renal cell carcinoma

In a study of patients with high-risk renal cell carcinoma, those who took the drug everolimus daily for up to one year after surgery lived longer without their disease returning (recurrence-free survival, or RFS) than those who did not take everolimus, although the results narrowly missed the clinical trial's prespecified level for statistical significance.

4 Jun 2022

Ibrutinib plus chemoimmunotherapy prolonged progression-free survival in previously untreated mantle cell lymphoma patients

Combination chemoimmunotherapy with the Bruton's tyrosine kinase (BTK) inhibitor ibrutinib demonstrated improved progression-free survival over standard chemoimmunotherapy for previously untreated mantle cell lymphoma (MCL) in patients 65 and over, researchers from The University of Texas MD Anderson Cancer Center reported today at the 2022 American Society of Clinical Oncology Annual Meeting.

3 Jun 2022

New method to combat malaria turns the disease against itself

A new method to combat malaria which sees the disease turn against itself could offer an effective treatment for the hundreds of millions of people infected globally each year, as the efficacy of current antimalarial drugs weakens.

3 Jun 2022

Vaccination lowers the risk of experiencing severe COVID-19 in dialysis patients

In an analysis of patients with kidney failure receiving dialysis who had become infected with SARS-CoV-2, those who were vaccinated had a lower risk of experiencing severe COVID-19.

3 Jun 2022

Previous
1
...
11
12
13
14
15
16
17
...
1247
Next

Pharmaceuticals News and Research

New weight loss treatment is marked by heavy marketing and modest results

Simplicity is key when it comes to ablation, global AFib study finds

Insufficient drug exposure most likely to cause COVID-19 rebound

A proposal to import drugs from other countries creates an unusual alliance in the Senate

Oral immunotherapy for peanut allergies is highly effective when started for infants under 12 months

At a Bay Area ‘test-to-treat’ site, few takers for free antivirals

Study tracks neurological symptoms in COVID-19 "long-haulers"

Drug combinations may help to slow the progression of diabetic kidney disease

As Biden fights overdoses, harm reduction groups face local opposition

First-in-class, anti-cancer mitochondrial drug found to be effective against most carcinoma cell lines

KHN’s ‘What the Health?’: Taking a shot at gun control

Robotic finger covered with living skin tissue can heal itself

Largest-ever series of case studies shows phage therapy’s success in more than half of the patients

Lawmaker takes on insurance companies and gets personal about his health

Misinformation clouds America’s most popular emergency contraception

Etiologies of liver cancer are changing and the prognosis is mixed, study says

Taking everolimus post-surgery can improve outcomes in patients with high-risk renal cell carcinoma

Ibrutinib plus chemoimmunotherapy prolonged progression-free survival in previously untreated mantle cell lymphoma patients

New method to combat malaria turns the disease against itself

Vaccination lowers the risk of experiencing severe COVID-19 in dialysis patients

Exploring the intersection of biology and proteomics

Unlocking the Secrets of Multiple Sclerosis Progression: Brain-Immune Cell Communication

Passing on Polycystic Ovary Syndrome: Health risks for male offspring of women with PCOS

Latest Life Science News